#Crop disease prevention

[crop-insurance]

Understanding the importance of crop Insurance | Kshema General Insurance

Farming in India is not just an occupation; it is a way of life for millions of small and marginal farmers. However, the unpredictable nature of agriculture—driven by erratic weather and market fluctuations — makes it one of the riskiest livelihoods. For a small farmer, a single failed crop can lead to catastrophic financial consequences, trapping them in a cycle of debt and poverty. 

This is where crop insurance becomes a game-changer. Despite its affordability, many farmers fail to understand the importance of crop insurance.

Why Farmers Avoid Crop Insurance 

Despite its numerous benefits, many farmers in India fail to understand the Importance of Crop Insurance and remain uninsured. The reasons include: 

Lack of Awareness: Many farmers are unaware of crop insurance schemes or how they work. 

Perceived Cost: Farmers assume that the insurance premiums are expensive, without realising how affordable they can be. 

Complex Processes: Farmers often feel intimidated by the documentation and procedures involved in insurance enrollment. 

These misconceptions prevent farmers from taking advantage of a safety net that can save them from financial ruin. 

Kshema Sukriti Crop Insurance: Affordable Protection 

At Kshema General Insurance, we understand the importance of crop insurance and the challenges faced by small and marginal farmers. Our Sukriti Crop Insurance policy is specifically designed to offer comprehensive protection at an affordable cost. 

Key Features of Kshema Sukriti: 

Affordable Premium: Starting at just Rs 499, it is one of the most affordable crop insurance options available to the farmers in more than 20 states and union territories in India.  

Wide Coverage: Mitigates loss of crops due to natural disasters and animal attacks (elephants, wild boars, monkeys, and rabbits).  

Easy Enrollment: Hassle-free, mobile app-based processes to make crop insurance accessible to all farmers.   

Timely Compensation: Quick claim settlements to help farmers recover and restart their operations.  

Customisation: Choice of 2 perils among a list of 8 predefined perils so that the farmers pay for only what they perceive as a danger to their crops.  

By enrolling in Kshema Sukriti, farmers can avoid the crippling financial burden of crop failures and secure their livelihoods. 

Read More: https://kshema.co/understanding-the-importance-of-crop-insurance/

[sonalikrishnan]

Understanding the importance of crop Insurance | Kshema General Insurance

Farming in India is not just an occupation; it is a way of life for millions of small and marginal farmers. However, the unpredictable nature of agriculture—driven by erratic weather and market fluctuations — makes it one of the riskiest livelihoods. For a small farmer, a single failed crop can lead to catastrophic financial consequences, trapping them in a cycle of debt and poverty. 

This is where crop insurance becomes a game-changer. Despite its affordability, many farmers fail to understand the importance of crop insurance.

Why Farmers Avoid Crop Insurance 

Despite its numerous benefits, many farmers in India fail to understand the Importance of Crop Insurance and remain uninsured. The reasons include: 

Lack of Awareness: Many farmers are unaware of crop insurance schemes or how they work. 

Perceived Cost: Farmers assume that the insurance premiums are expensive, without realising how affordable they can be. 

Complex Processes: Farmers often feel intimidated by the documentation and procedures involved in insurance enrollment. 

These misconceptions prevent farmers from taking advantage of a safety net that can save them from financial ruin. 

Kshema Sukriti Crop Insurance: Affordable Protection 

At Kshema General Insurance, we understand the importance of crop insurance and the challenges faced by small and marginal farmers. Our Sukriti Crop Insurance policy is specifically designed to offer comprehensive protection at an affordable cost. 

Key Features of Kshema Sukriti: 

Affordable Premium: Starting at just Rs 499, it is one of the most affordable crop insurance options available to the farmers in more than 20 states and union territories in India.  

Wide Coverage: Mitigates loss of crops due to natural disasters and animal attacks (elephants, wild boars, monkeys, and rabbits).  

Easy Enrollment: Hassle-free, mobile app-based processes to make crop insurance accessible to all farmers.   

Timely Compensation: Quick claim settlements to help farmers recover and restart their operations.  

Customisation: Choice of 2 perils among a list of 8 predefined perils so that the farmers pay for only what they perceive as a danger to their crops.  

By enrolling in Kshema Sukriti, farmers can avoid the crippling financial burden of crop failures and secure their livelihoods. 

Read More: https://kshema.co/understanding-the-importance-of-crop-insurance/

[farmerstrend]

A Comprehensive Farming Guide on Tomato Fertilization

Tomato farming in Kenya is one of the most profitable agricultural crops due to the growing demand for tomatoes in both local and international markets. With the country’s population expanding, the consumption of tomatoes, a staple in Kenyan dishes, has increased, making it a viable option for many farmers looking to diversify their farming activities. Kenya’s climate is suitable for tomato…

[umangharyana]

Yellow Rust, Wheat Disease : कांगड़ा में पीला रतुआ से गेहूं फसल को बचाने के लिए कृषि विभाग ने क्या कदम उठाए?

कांगड़ा जिले के किसानों के लिए एक खतरनाक खतरा उत्पन्न हो गया है। पीला रतुआ, गेहूं की फसल को बर्बाद करने वाला एक खतरनाक रोग, ने किसानों की चिंता बढ़ा दी है। लेकिन कृषि विभाग इस संकट से निपटने के लिए पूरी ताकत से जुटा हुआ है। कृषि विकास खंड परागपुर में कृषि विभाग की टीम ने गेहूं की फसल का निरीक्षण किया और किसानों को इस खतरनाक रोग से बचने के लिए जागरूक किया। कृषि अधिकारियों ने इस रोग के लक्षणों को…

[cybermanoloart]

The last video of the plant month serie! Exactly one week late but oh well 😅

We're two sisters collaborating on this video serie

@cybermanolol is in charge of the art and the editing 🎨 📽️ and @_chalulu_ is the one doing all the plant research and she's also the voice 📝🗣️

@_chalulu_ my sources are:

- Le régal végétal by François Couplan

- Cueillette buissonnière dans le bocage, usage populaire des plantes sauvages en Thiérache - Pays de Chimay. Edition 2020.

@cybermanoloart I've seen lots of paintings of dandelions, so I searched for a way to make one that was truly mine and original. @_chalulu_ is a little disappointed that it doesn't feature the plant more predominantly, but I wanted to showcase the dandelion's ability to grow into the most hostile of environments. What do you think about it? Agree with my sister, or do you like this Idea?

Choose your harvesting location well:

Do not enter private property and never harvest in a protected area. Also avoid roadsides or polluted sites.

Be sure to correctly identify everything you pick so as not to damage a rare species or poison yourself.

When in doubt, abstain or call someone with the relevant competence.

Harvest plants sparingly, only where they are abundant and never collect too much.

Take only as needed and do not pull out the entire crops.

Wash before eating.

Carefully sort and wash the crop. Be careful, only cooking can prevent certain diseases or parasites such as echinococcosis or liver fluke.

[kohanakonohana]

noteからの翻訳です。日本語の方はぜひ末尾のリンクから向こうへ。

The silkworm makes a cocoon to protect itself when it becomes a pupa. The length of the thread that is ejected while swinging its head in a figure eight motion is said to be as long as 1,300 meters or more. 1,300m or even longer in some varieties.

The raw silk I usually use to weave kimonos is a thin, fine thread, and those threads I usually use to weave kimonos is made by twisting 10 strands of 7-grain yarn. In other words, it is the thickness of 70 cocoons.

When drawing raw silk, cocoons are boiled and the protein (sericin), which is like glue that holds the yarn together, is broken down and drawn out. The figure of eight(8) is the secret to prevent tangling in the middle.

So. we could find a silkworm or moss after we pull and take a long thread from inside. (They will not become adult silkworms, though, because they are boiled.

Raw silkworms can be boiled, or the amount of work required to take the thread from them is limited. Recently, we have been drying, freezing, salting (salting method), and steaming (steaming method), etc., to produce raw silk. In short, it is necessary to prevent the silkworms from leaving their cocoons as adult worms.

Because …silkworms first hatch in cocoons, but they have to make a hole in the cocoon they made themselves to get out.

For the time being, they finish their transformation into the form of a moth inside and tear the skin of their chrysalis, the silkworm then breaks through the chrysalis skin and expels an enzyme called cochonase, which is produced in the organ called the bird's crop sac.

The moth then breaks through the chrysalis skin, and exhales an enzyme called cochonase, produced in the organ called the bird's craw sac, to soften the sericin at the exit, then emerges from the chrysalis by pushing its way through the threads.

Furthermore, when it comes out, it also produces urine, or water, which is called "moth urine". and coloured and stains the inside of the cocoon. The rest is the skin of the shed pupa, which also sticks to the inside of the cocoon.

The silkworms hatch and the quality of the cocoons changes,

The quality of the cocoon changes and raw silk cannot be obtained. The enzyme does not break the thread itself, but the cocoonase is alkaline, so it does not do much damage to weakly acidic fibres.

However, cocoonase is alkaline, so there is no small amount of damage to weakly acidic fibres. Nevertheless, at least some of the silkworms have to be made into adult worms, because the silkworm eggs for the next cycle cannot be obtained.

The cocoons from which raw silk was not obtained, and the rest from disease, or the cocoons that did not produce raw silk, cocoons that were too small because of disease or poor growth, and so on.

It is Japanese culture not to waste such things. The cocoons are boiled, the sericin in the paste is broken down, and the pupal skin is removed as much as possible, and the result is cotton-like material known as "mawata".

Mawata sheets

The "tsumugi" thread is made by stretching and twisting the cotton, either by pulling it out or twisting it, or neither, or both. Then, fabrics woven using the tsumugi thread is called tsumugi weaving.

The left is raw silk and the right is tsumugi yarn spun by myself.The texture is different. Such is the case even with purchased products.

To be precise, the silkworm's thread is called "kibiso"

The silkworm's thread is made up of three parts: the beginning part, called kibiso ; the long, long raw silk part; and the end part, called "bisu".

Both kibiso and bisu have different textures from raw silk, and sometimes only these parts are collected and sold as separate yarns.

The beginning of the spit is still unstable and the end is the residue of the body, so in essence, I have heard that they are made slightly differently...In the case of the easily recognisable coloured silkworm cocoons, the hard yellow-green outer part is the kibiso,

The bis has a light yellow-green raw silk part inside, and the bis is slightly yellowish white.)

The bisu ends up looking leathery and unravelling…

Those different textures remain in the mawata, so, even if you try to stretch them out homogeneously, it is sometimes impossible to do so. That is the true nature of the knots that remain in the silk threads.

Kibiso (left) and bisu (right) of wild silkworms.(Silkworms ones do not peel so much)

In the end, what I wanted to say was that thread is a gift of life,I think it is lovely that the thread is born out of such a sense of waste.

[covid-safer-hotties]

Also preserved on our archive (Daily updates!)

By Stephani Sutherland

Gentle nasal spray vaccines against COVID, the flu and RSV are coming. They may work better than shots in the arm

Alyson Velasquez hates needles. She never liked getting shots as a kid, and her anxiety only grew as she got older. “It really ballooned in my teens and early 20s,” she says. “It became a full-blown phobia.” She would panic at the sight of a needle being brought into an exam room; more than once she passed out. Velasquez says that she took an antianxiety medication before one appointment yet still ran around the room screaming inconsolably “like I was a small child; I was 22.” After that episode Velasquez, now a 34-year-old financial planner in southern California, quit needles completely. “No vaccinations, no bloodwork. For all of my 20s it was a no-go for me,” she says.

Then COVID showed up. “It finally hit a point where it wasn’t just about me,” Velasquez says. “It felt so selfish not to do this for the greater public health and the safety of our global community.” So she got vaccinated against the SARS-CoV-2 virus in 2021, although she had to sit on her husband’s lap while he held her arms. “It was a spectacle. The poor guy at CVS ... he did ask me, ‘Are you sure you want to do this?’” She very much did. “I’m very pro-vaccine. I am a rational human. I understand the necessity of [getting] them,” she insists. But today she still struggles with each injection.

Those struggles would end, however, if all her future vaccinations could be delivered by a nasal spray. “Oh, my God, amazing!” Velasquez says.

The amazing appears to be well on its way. Vaccines delivered through the nose are now being tested for several diseases. In the U.S., early clinical trials are showing success. Two of these vaccines have generated multiple immune system responses against the COVID-causing virus in people who received them through a puff up the nose; earlier this year their makers received nearly $20 million from Project NextGen, the Biden-Harris administration’s COVID medical initiative. Researchers are optimistic that a nasal spray delivering a COVID vaccine could be ready for the U.S. as soon as 2027. Although recent efforts have focused on inoculations against SARS-CoV-2, nasal vaccines could also protect us against the flu, respiratory syncytial virus (RSV), and more.

A few nasal vaccines have been introduced in the past, but they’ve been beset by problems. The flu inoculation FluMist has not gained popularity because of debates about its effectiveness, and a different vaccine was pulled from the market decades ago because some people had serious side effects. In China and India, nasal vaccines for COVID have been approved because those countries prioritized their development during the pandemic, whereas the U.S. and other wealthy nations opted to stick with arm injections. But this new crop of vaccines takes advantage of technology that produces stronger immune responses and is safer than preparations used in the past.

In fact, immunologists say these spritzes up the nose—or inhaled puffs through the mouth—can provide faster, stronger protection against respiratory viruses than a shot in the arm. That is because the new vaccines activate a branch of the immune system that has evolved for robust, rapid responses against airborne germs. “It may be more likely to really prevent infection from getting established,” says Fiona Smaill, an infectious disease researcher at McMaster University in Ontario. Such inoculations may also help reduce the enormous inequities in vaccine access revealed by the pandemic. These formulations should be cheaper and easier to transport to poor regions than current shots.

But nasal vaccines still face technical hurdles, such as how best to deliver them into the body. And unlike injected vaccines, which scientists can measure immune responses to with blood tests alone, testing for immunity that starts in nose cells is more challenging. But researchers working in this field agree that despite the hurdles, nasal formulations are the next step in vaccine evolution.

Traditional vaccines injected through the skin and into an arm muscle provide excellent protection against viruses. They coax immune cells into making widely circulated antibodies—special proteins that recognize specific structural features on viruses or other invading pathogens, glom on to them and mark them for destruction. Other immune cells retain a “memory” of that pathogen for future encounters.

Intramuscular injection vaccines are good at preventing a disease from spreading, but they do not stop the initial infection. A nasal spray does a much better job. That’s because sprays are aimed directly at the spot where many viruses first enter the body: the nose and the tissue that lines it, called the mucosa.

Mucosa makes up much of our bodies’ internal surfaces, stretching from the nose, mouth and throat down the respiratory tract to the lungs, through the gastrointestinal tract to the anus, and into the urogenital tract. Mucosa is where our bodies encounter the vast majority of pathogenic threats, Smaill says, be it flu, COVID, or bacterial infections that attack the gut. This tough, triple-layered tissue is specialized to fight off invaders with its thick coating of secretory goo—mucus—and with a cadre of resident immune cells waiting to attack. “Mucosa is really the first line of defense against any infection we’re exposed to,” Smaill says.

Mucosal immunity not only prepares the immune system for the fight where it occurs but also offers three different types of protection—at least one more than a shot does. Nasal vaccines and shots both mobilize immune messenger cells, which gather the interlopers’ proteins and display them on their surfaces. These cells head to the lymph nodes, where they show off their captured prize to B and T cells, which are members of another part of the immune system called the adaptive arm. B cells, in turn, produce antibodies, molecules that home in on the foreign proteins and flag their owners—the invading microbes—for destruction. Killer T cells directly attack infected cells, eliminating them and the microbes inside. This provides broad protection, but it takes time, during which the virus continues to replicate and spread.

That’s why a second type of protection, offered only by the mucosal tissue, is so important. The mucosa holds cells of the innate immune system, which are the body’s “first responders.” Some of these cells, called macrophages, recognize invasive microbes as foreign and swallow them up. They also trigger inflammation—an alarm sounded to recruit more immune cells.

Another part of this localized response is called tissue-resident immunity. These cells don’t have to detect telltale signs of a pathogen and make a long journey to the infected tissue. They are more like a Special Forces unit dropped behind enemy lines where a skirmish is occurring rather than waiting for the proverbial cavalry to arrive. This localized reaction can be quite potent. Its activation is notoriously difficult to demonstrate, however, so historically it’s been hard for vaccine makers to show they’ve hit the mark. But it turns out that one type of antibody, called IgA, is a good indicator of mucosal immunity because IgAs tend to predominate in the mucosa rather than other parts of the body. In an early trial of CoviLiv, a nasal COVID vaccine produced by Codagenix, about half of participants had detectable IgA responses within several weeks after receiving two doses. That trial also showed the vaccine was safe and led to NextGen funding for a larger trial of the vaccine’s efficacy.

It’s possible an inhaled vaccine may provide yet one more layer of protection, called trained innate immunity. This reaction is a bit of a mystery: although immunologists know it exists and appears also to be produced by intramuscular injections, they can’t quite explain how it works. Immune cells associated with trained innate immunity seem to have memorylike responses, reacting quickly against subsequent infections. They also have been found to respond against pathogens entirely unrelated to the intended vaccine target. Smaill and her colleagues found that when they immunized mice with an inhaled tuberculosis vaccine and then challenged them with pneumococcal bacteria, the mice were protected. In children, there is some evidence that a tuberculosis vaccine, in the arm, generates this type of broad response against other diseases.

Akiko Iwasaki, an immunologist at Yale University who is working to develop a nasal vaccination for COVID, sees two major potential benefits to nasal immunity in addition to better, faster, more localized protection. First, attacking the virus in the nose could prevent the disease from being transmitted to others by reducing the amount of virus that people breathe out. And second, Iwasaki says, the spray may limit how deeply the infection moves into the body, so “we believe that it will also prevent long COVID.” That debilitating postinfection condition, sometimes marked by signs of entrenched viral particles, disables people with extreme fatigue, chronic pain, a variety of cognitive difficulties, and other symptoms.

Making a new vaccine is hard, regardless of how you administer it. It needs to raise an immune response that’s strong enough to protect against future invasions but not so strong that the components of that response—such as inflammation and fever—harm the host.

The lining of the nose puts up its own barriers—literal, physical ones. Because the nasal mucosa is exposed to so many irritants from the air, ranging from pet hair to pollen, the nose has multiple lines of defense against invading pathogens. Nostril hair, mucus, and features called cilia that sweep the nasal surface all aim to trap small foreign objects before they can get deeper into the body—and that includes tiny droplets of vaccine.

And lots of small foreign particles—often harmless—still make it through those defenses. So the nose has developed a way to become less reactive to harmless objects. This dampened reactivity is called immunological tolerance, and it may be the biggest hurdle to successful development of a nasal vaccine. When foreign particles show up in the bloodstream, a space that is ostensibly sterile, immune cells immediately recognize them as invaders. But mucosal surfaces are constantly bombarded by both pathogens and harmless materials. The immune system uses tolerance—a complex series of decisions carried out by specialized cells—to determine whether a substance is harmful. “This is very important because we can’t have our lungs or gastrointestinal tract always responding to nonharmful foreign entities that they encounter,” says Yale infectious disease researcher Benjamin Goldman-Israelow. For example, inflammation in the lungs would make it hard to breathe; in the gut, it would prevent the absorption of water and nutrients.

These barriers may hamper the effectiveness of a nasal flu vaccine that’s been around for a while, called FluMist in the U.S. and Fluenz in Europe. The inoculation is safe, says infectious disease scientist Michael Diamond of Washington University in St. Louis, but it faces a similar problem as do injected flu vaccines: it isn’t very effective at warding off new seasonal flu strains. This might be because flu strains are so common, and people are frequently infected by the time they are adults. Their immune systems are already primed to recognize and destroy familiar flu particles. FluMist is built from a live flu virus, so immune cells probably treat the vaccine as an invader and demolish it as soon as it shows up in the nose, before it has a chance to do any good. This preexisting immunity isn’t such an issue in children, who are less likely to have had multiple flu infections. Nasal flu vaccines are routinely used to inoculate kids in Europe.

In other vaccines, researchers often use adjuvants, special agents that attract the attention of immune cells, to boost a response. Some nasal vaccines use adjuvants to overcome tolerance, but in the nose, adjuvants can pose unique dangers. In at least one case, a nasal adjuvant led to disastrous consequences. An intranasal vaccine for influenza, licensed in Switzerland for the 2000–2001 season, used a toxin isolated from Escherichia coli bacteria as an adjuvant to provoke a reaction to the inactivated virus. No serious side effects were reported during the trial period, but once the vaccine was released, Swiss officials saw a concerning uptick in cases of Bell’s palsy, a disease that causes weakness or paralysis of the facial muscles, often leading to a drooping or disfigured face. Researchers at the University of Zurich estimated that the adjuvanted flu vaccine had increased the risk of contracting Bell’s palsy by about 20 times, and the vaccine was discontinued. “We need to be cautious about using adjuvants like that from known pathogens,” says pharmaceutical formulations scientist Vicky Kett of Queen’s University Belfast in Northern Ireland.

To get around the challenges posed by the nose, some researchers are exploring vaccines inhaled through the mouth. Smaill is working on one of them. She and her McMaster colleagues aerosolized their vaccine for COVID into a fine mist delivered by a nebulizer, from which it rapidly reaches the lungs. Experiments in mice have shown promising results, with mucosal immunity established after administration of the vaccine.

Another vaccine strategy is to use a harmless virus to carry viral genes or proteins. Researchers at the Icahn School of Medicine at Mount Sinai in New York City selected a bird pathogen, Newcastle disease virus (NDV). “It’s naturally a respiratory pathogen,” so it infects nasal cells, says Michael Egan, CEO and chief scientific officer of CastleVax, a company that formed to develop the NDV vaccine for COVID. A small early clinical trial showed the CastleVax vaccine was safe and caused robust immune responses in people. “Those results were very promising,” Egan says. People who received the vaccine also produced antibodies that indicated multitiered mucosal immunity, not simply the adaptive immunity from a shot in the arm.

Following that trial, the CastleVax project received NextGen funding, and results from a trial of 10,000 people are expected in 2026. Half of those people will receive a messenger RNA (mRNA) injection, and half will get the new NDV nasal spray. The data should show whether the new nasal vaccine can do a better job of preventing infection than the mRNA injections. Egan has high hopes. “We’re expecting to see a lot fewer breakthrough infections in people who got the vaccine up the nose by virtue of having those mucosal immune responses,” he says.

Florian Krammer, one of the Mount Sinai researchers behind the vaccine, engineered NDV particles to display a stabilized version of the spike protein that’s so prominent in SARS-CoV-2. “You end up with a particle that’s covered with spike,” he says. Spike protein in the blood­stream can raise an immune response. But the NDV vaccine works in another way, too. The virus particle can also get into cells, where it can replicate enough times to cause virus particles to emerge from the cells, provoking another immune reaction. Before moving into human trials, however, researchers had to complete clinical trials to establish that the Newcastle virus is truly harmless because the nose is close to the central nervous system—it has neurons that connect to the olfactory bulb, which is part of the brain. Those trials confirmed that it is safe for this use.

Nasal sprays aim directly at the spot where most viruses first enter the body: the nose. This type of caution is one reason a COVID nasal vaccine approved in India hasn’t been adopted by the U.S. or other countries. The inoculation, called iNCOVACC, uses a harmless simian adenovirus to carry the spike protein into the airway. The research originated in the laboratories of Diamond and some of his colleagues at Washington University at the start of the pandemic, when they tested the formulation on rodents and nonhuman primates. “The preclinical data were outstanding,” Diamond says. Around the time he and his colleagues published initial animal results in Cell in 2020, Bharat Biotech in India licensed the idea from the university. In a 2023 phase 3 clinical trial in India, the nasal vaccine produced superior systemic immunity compared with a shot.

Diamond says American drug companies didn’t pursue this approach, because “they wanted to use known quantities,” such as the mRNA vaccines, which were already proving themselves in clinical trials in 2020. As the pandemic took hold, there was little appetite to develop nasal vaccine technology to stimulate mucosal immunity while the tried-and-true route of shots in the arm was available and working. But now, four years later, an inhaled vaccine using technology similar to iNCOVACC’s is being developed for approval in the U.S. by biotech company Ocugen. Both inhaled and nasal forms of the vaccine are set to undergo clinical trials as part of Project NextGen. These new vaccines are using classical vaccine methods based on the virus rather than using new, mRNA-based technology. The mRNA preparations were developed specifically for intramuscular injections and would have to be significantly modified.

Codagenix, which is developing CoviLiv, sidestepped the need for a new viral vector or an adjuvant by disabling a live SARS-CoV-2 virus. To make it safe, scientists engineered a version of the virus with 283 mutations, alterations to its genetic code that make it hard for the virus to replicate and harm the body. Without all these genetic changes, there would be a chance the virus could revert to a dangerous, pathogenic form. But with hundreds of key mutations, “statistically, it’s basically impossible that this will revert back to a live virus in the population,” says Johanna Kaufmann, who helped to develop the vaccine before leaving Codagenix for another company earlier this year.

Because most people on the planet have now been exposed to SARS-CoV-2—in the same way they’re regularly exposed to the flu—some nasal vaccines are being designed as boosters for a preexisting immune response that is starting to wane. For example, Yale researchers Iwasaki and Goldman-Israelow are pursuing a strategy in animals deemed “prime and spike.”

The idea is to start with a vaccine injection—the “prime” that stimulates adaptive immunity—then follow it a few weeks later with a nasal puff that “spikes” the system with more viral protein, leading to mucosal immunity. In a study published in 2022 in Science, Iwasaki and her colleagues reported that they primed rodents with the mRNA vaccine developed by Pfizer and BioNTech, the same shot so many of us have received. Two weeks later some of the mice received an intranasal puff of saline containing a fragment of the SARS-CoV-2 spike protein. Because the animals had some preexisting immunity from the shot, the researchers didn’t add any adjuvants to heighten the effects of the nasal puff. Two weeks later researchers detected stronger signs of mucosal immunity in mice that had received this treatment compared with mice that got only the shot.

“Not only can we establish tissue-resident memory T cells” to fight off the virus in the nose, Iwasaki says, but the prime-and-spike method also produces those vigorous IgA antibodies in the mucosal layer. “And that’s much more advantageous because we can prevent the virus from ever infecting the host,” she notes. The study suggests that this approach might also lessen the chances of transmitting the disease to others because of the lower overall viral load. Experiments in hamsters demonstrated that vaccinated animals shed less virus, and they were less likely to contract COVID from infected cage mates that had not been vaccinated themselves.

Although most of the new vaccine strategies are aimed at COVID, nasal vaccines for other diseases are already being planned. Kaufmann, formerly of Codagenix, says the company currently has clinical trials underway for nasal vaccines against flu and RSV. CastleVax’s Egan says “we have plans to address other pathogens” such as RSV and human metapneumovirus, another leading cause of respiratory disease in kids.

Vaccines that don’t need to be injected could clear many barriers to vaccine access worldwide. “We saw with COVID there was no vaccine equity,” Smaill says. Many people in low-income countries never received a shot; they are still going without one four years after the vaccines debuted.

In part, this inequity is a consequence of the high cost of delivering a vaccine that needs to stay frozen on a long journey from manufacturing facilities in wealthy countries. Some of the nasal sprays in development don’t need deep-cold storage, so they might be easier to store and transport. And a nasal spray or an inhaled puff would be much easier to administer than a shot. No health professional is required, so people could spray it into their noses or mouths at home.

For these reasons, needle-free delivery matters to the World Health Organization. The WHO is using the Codagenix nasal spray in its Solidarity Trial Vaccines program to improve vaccine equity. The CoviLiv spray is now in phase 3 clinical trials around the world as part of this effort. “The fact that the WHO was still interested in a primary vaccination trial in the geographies it’s passionate about—that’s indicative that there is still a gap,” Kaufmann says. CoviLiv was co-developed with the Serum Institute of India, the world’s largest maker of vaccines by dose. The partnership enabled production at the high volume required for Solidarity.

The CastleVax vaccine with the NDV vector provides another layer of equity because the facilities required to make it already exist in many low- and middle-income countries. “The cool thing is that NDV is a chicken virus, so it grows very well in embryonated eggs—that’s exactly the system used for making flu vaccines,” Krammer says. For example, for a clinical trial in Thailand, “we just shipped them the seed virus, and then they produced the vaccine and ran the clinical trials,” he says. Many countries around the world have similar facilities, so they will not need to depend on pharma companies based in richer places.

Even high-income countries face barriers to vaccination, although they may be more personal than systemic. For very many people, the needle itself is the problem. Extreme phobia such as Velasquez’s is uncommon, but many people have a general fear of needles that makes vaccinations stressful or even impossible for them. For about one in 10 people needle-related fear or pain is a barrier to vaccinations, says C. Meghan McMurtry, a psychologist at the University of Guelph in Ontario. Needle fear “is present in most young kids and in about half of adolescents. And 20 to 30 percent of adults have some level of fear.” A review of studies of children showed that “concern around pain and needle fear are barriers to vaccination in about 8 percent of the general population and about 18 percent in the vaccine-hesitant population,” McMurtry adds.

Some people are wary of injected vaccines even if they’re not afraid of needles, Kett says; they see injections as too invasive even if the needle doesn’t bother them. “We’re hopeful that something administered by the nasal route would be less likely to come across some of those issues,” Kett says.

In the U.S., however, sprays and puffs won’t be available until they are approved by the Food and Drug Administration, which requires clear evidence of disease protection. As Diamond points out, standards for such evidence are well established for injections, and vaccine makers can follow the rule book: regulations point to particular antibodies and specific ways to measure them with a simple blood test. But for nasal vaccines, Iwasaki says, “we don’t have a standard way to collect nasal mucus or measure antibody titers. All these practical issues have not been worked out.”

Iwasaki is also frustrated with a restriction by the U.S. Centers for Disease Control and Prevention that stops researchers from using existing COVID vaccines in basic research to develop new nasal sprays. The rule is a holdover from 2020, when COVID injections had just been developed and were in short supply; people had to wait to get vaccinated until they were eligible based on factors such as age and preexisting conditions. “That made sense back then, but those concerns are years old; things are different now,” Iwasaki says. “Now we have excess vaccine being thrown out, and we cannot even get access to the waste, the expired vaccine.”

Today scientists want to contrast the effectiveness of nasal formulations with injections already in use. “Those comparisons are really important for convincing the FDA that this is a worthy vaccine to pursue,” Iwasaki says. But the restriction has held up studies by her company, Xanadu, slowing down work. (The CDC did not respond to a request for comment.)

Despite the bureaucratic and scientific hurdles, the sheer number of nasal vaccines now in clinical trials encourages Iwasaki and other scientists pursuing the needle-free route. They say it seems like only a matter of time before getting vaccinated will be as simple as a spritz up the nose.

Velasquez, for one, can’t wait for that day to arrive. The circumstances that finally forced her to reckon with her fear of needles (a global pandemic, the prospect of parenthood and the numerous blood tests that accompanied her pregnancy) were so much bigger than her. If not for them, she might still be avoiding shots. “So having vaccines without needles—I would get every vaccine any doctor wanted me to get, ever. It would be a complete game changer for me.”

[kedreeva]

Hi! Jumping off your previous post on keeping peafowl as pets I've been wondering - I work at a botanical garden but we have a few animals around as well, among them peafowl. They regularly sleep in high trees, like. idk. 15-30m (50-165ft?) height and you've been mentioning a height of like 8ft. So anyway I've been wondering: Do Peafowl enjoy but not need so much height? Is there a minimum height requirement at all?

The minimum height is a bit contested among keepers, but MOST people will rec at least 8 feet. This isn't for any disease/parasite/illness health reason like pen square footage (which is the square footage needed to keep grass/cover crop in a pen, so the peafowl don't kill it to the point of bare earth, which can give them a lot of health problems), but rather for feather quality. 8 feet minimum allows you to keep at least one 4-5ft tall perch in the pen, which is the height that allows the males to sit on them without his train touching the ground. This prevents the tips of his train (the frame feathers) from getting messed up, and allows them to preen from a perch instead of the ground (which is how the boys prefer, though they'll do both, you'll see them at it more often up higher).

The reason they sleep high in trees is because it keeps them away from most predators. There isn't a LOT of stuff that can and will kill a peacock in their native land, and most of it is not going to be climbing 100 feet in the air to tussle with a 10-15lb bird in the dark when it doesn't have wings, too. Even the smaller cats like civets might hesitate to get up after them. In captivity, they don't have predators in their pen (I hope), so there's no reason they NEED to be up super high. As long as they're off the ground and their trains aren't touching the ground, they're fine. They'll still work to get as high as they can (mine in the barn figured out how to get up to this little itty bitty 2x4 I screwed to the rafters for the pigeons to roost on, back in the day), and they like to be up high, but it's not something that will make them unhealthy if they don't sleep 50+ feet up.

Most folks are pretty capable of building 8-12 feet or so high (three of my pens are 8ft, the biggest is 12ft) without too much extra in cost or effort. The lumber or other materials needed to do this are readily available at big box hardware stores here, so it doesn't involve any special ordering or engineering to create pens that meet that kind of requirement safely and without tangling with their town's laws about construction of buildings. I've seen a few people who had access to construction equipment build pens out of I-beam and poles and welded wire and stuff, 30-40 feet high and massive, which was really cool, but ultimately not a MINIMUM- and it's important to recognize that all of these measurements ARE minimums- if you have the ability to build bigger/better then by all means you should go for it, but meeting the minimum still meets the needs of the birds just fine.

But since there isn't an established minimum on height (or if there is, it's outdated at 6 feet) and it's CHEAPER to build to 6ft than to 8ft, and that's what some people do- and shouldn't, because that doesn't give the birds enough room to preen and keep their feathers clean and in shape. It may not make them sick outright, but it sure as hell will lead to a ratty looking bird you won't enjoy as much.

[homeofhousechickens]

Hii, I saw your Marek's disease post, my cousin has a hen that has this kind of eye but she's ok, she eats, moves and everything, do you maybe know if this type can also evolve and become the most dangerous types like the paralysis? I'll be glad if you can answer and hope you have a great day

There are 5 different "forms" of Mareks and different "strains" of the virus that are more lethal or infectious then others. It's possible for a bird to present with multiple symptoms and forms when they have the disease.

Nerve form- Birds with this form have tumors infiltrate into their peripheral nerves. This causes symptoms like wry neck and sometimes a head tilt. It can also cause a chicken to have a slow crop and have trouble emptying. 20% of birds with this form die

Transient paralysis form - Causes brain edema and ataxia. The bird can have partial paralysis of the neck and legs. Usually, you will see these birds trying to use their wings to get around while falling over a bunch. 30% of birds with this form will die.

Ocular form- The virus replicates in the eye, causing tumors and vision loss. This causes the shape and color of the eye to change. 25% of birds with this form will die.

Skin form- The virus replicates in the skin causing tumor growth and enlarged feather follicles. Usually the location for these is around the head, legs, and vent. The bird will be lumpy and might have wonky feather growth but that's usually it. This form has the lowest mortality rate.

Visceral form- Tumors develop all throughout the body and onto the internal organs. The symptoms will present differently depending on what organs and systems are affected. 60-80% of birds with this form will die.

For chickens with Ocular Mareks they are usually older birds that have a bit of an immunity to the virus which is why their body is able to kind of suppress it but unfortunately the chicken can still have tumor development elsewhere in her body especially if her immune system gets compromised by a different illness like coccidosis or fowl pox.

If your girl has the Ocular form you must assume the rest of your flock has it and it's possible for it to present as the other forms. Mareks can stay dormant in a host for a long time then pop out when the birds immune system is weakened.

For anyone reading this and getting worried..

YOU CAN TEST FOR MAREKS! A lot of people don't know you can test living birds for the disease but it can also be diagnosed via necropsy. Your vet can help you with the testing but you can also do the testing yourself using something like VetDNA.com.

To avoid Mareks you can get your birds vaccinated and only purchase from NPIP certified flocks. The vaccine won't stop the spread of the disease but it can prevent birds from showing symptoms. If you have a mareks positive flock it's important to keep them on your property and dont sell them or show them as they can infect other birds.

Good biosecurity practices are a must and the best way to prevent an outbreak is running a closed flock. No adult or baby birds are added everything is hatched and raised on the property is the ideal. Of course accidents can still happen like if you have a close neighbor with an infected flock. Mareks spreads through the dander so it's important that infected birds don't share air space with non infected birds.

If your birds do have Mareks and you want a flock that isn't infected the best thing to do is either cull your current flock, or wait for them to pass naturally. There are certain cleaners like Rescue and Kennelsol that kill the Mareks virus so you would want to clean all old feeders and waterer with it (or get new ones) and I have seen people say to burn down the old coop as it can be tricky removing the dust from the crevices. Mareks can live in the soil for a long long time but like other viruses you can still work towards sanitizing and decomtaminating the soil.

You can still hatch eggs from Mareks infected birds as the disease doesn't transfer vertically.

Hopefully this is the information you were looking for

[smalllady]

Places in Mass Effect 2 - Horizon A temperate world that has hit the "sweet spot" for carbon-based life, Horizon has a nitrogen-oxygen atmosphere maintained by abundant indigenous photosynthetic plants and bacteria. While the native plants are not very palatable to humans, the soil conditions are such that a handful of introduced Earth species have flourished, and the colonists must take strict care to prevent ecological disasters. Genetically-engineered "terminator seeds" that grow nutritious but sterile crops to minimize outbreaks are the rule rather than the exception. Animals on Horizon appear to be exploding in diversity, similar to Earth's Cambrian period. Large flying insect analogues takes advantage of the thicker-than-Earth atmosphere and low gravity to grow enormous. Microbial life have proven relatively benign; a series of vaccinations for the most virulent strains of soil-borne diseases is all that is required for a visit. Population: 654,390 Colony Founded: 2168 Capital: Discovery Orbital Distance: 2.1 AU Orbital Period: 3.0 Earth Years Radius: 5402 km Day Length: 37.8 Earth Hours Atmospheric Pressure: 1.68 Earth Atmospheres Surface Temperature: 13 Celsius Surface Gravity: 0.7 G

[shentheauthor]

I hate drawing Shamura I HATE IT

Extras under the cut

Leshy:

He will just eat soil. He likes it, first of all, and second it actually helps him figure out soil quality

He likes how chaotically the crops are organized in the cult

But he also hates how the lamb doesn’t know anything about good farming practices

“STOP USING SHIT AS FERTILIZER”

Works with the yellow cat (Thistle)

Absolutely breaks decorations for fun

He’s in the pillory a lot because of this

Narinder is banned from the farms because leshy won’t stop trying to bite him

Kallamar is also banned because leshy doesn’t want him messing with the crops

Digs holes in the cult, then covers them up badly so people will fall in

Heket:

She’s actually really good at cooking, but she often refuses to cook well

So she’ll burn food on purpose

Steals crops from the storage chests

Literally always hungry

Conspires with leshy to steal more crops

Has trouble speaking, so she uses sign language

She also writes notes, but her handwriting is terrible

Kallamar is banned from the kitchen

Most of the cult is banned from the kitchen

Heket rules the kitchen with an iron fist

Hates the lamb SO much

Kallamar:

One of the most loyal of their siblings (desperation will do that)

Still a coward, but actually pretty chill??

“I’ve already experienced the worst death countless times, nothing could possibly be worse than that.”

Sass master

He really should not be allowed to be a doctor. He knows how to prevent diseases, yeah, but he doesn’t actually do his job

Will poison the food (which is why he’s banned from the kitchen)

Encourages the lamb to keep using shit as fertilizer

“I want to see how quickly pathogens will spread through this community”

Negative rizz, somehow gets bitches still

Actually very pathetic around his crushes

Entitled brat

MATERIAL GWORL

Shamura:

The most loyal aside from Narinder

Mostly because they’ve accepted their fate

*slaps top of their head* this spider can fit so much regret in them

Likes to spend time with kids

Very confused most of the time

On bad days, they call children by their siblings’ names

On REALLY bad days, they dissent and try to kill the lamb, thinking they’re still at war

The elders love Shamura

They miss Narinder so much

They still get prophecies, but they’re impossible to decipher now

Unless ;)

[sonalikrishnan]

Understanding the Importance of Crop Insurance

Farming in India is not just an occupation; it is a way of life for millions of small and marginal farmers. However, the unpredictable nature of agriculture—driven by erratic weather and market fluctuations — makes it one of the riskiest livelihoods. For a small farmer, a single failed crop can lead to catastrophic financial consequences, trapping them in a cycle of debt and poverty. 

This is where crop insurance becomes a game-changer. Despite its affordability, many farmers fail to understand the importance of crop insurance. In this blog, we will explore the financial risks farmers face without a crop insurance and how small premium for affordable crop insurance policies like Kshema Sukriti Crop Insurance, starting at just Rs 499/acre, is vital in safeguarding their livelihood. 

Risks Farmers Face Without Crop Insurance 

Agriculture in India is unpredictable because of its dependence on natural phenomena like the monsoon rains. Farmers toil for months, investing their time, effort, and hard-earned money into growing crops, but without insurance, they stand exposed to a host of risks: 

Financial Losses Due to Natural Calamities

India’s agriculture is highly dependent on the monsoon due to the lack of uniform irrigation facilities across the country, while extreme weather conditions like cyclones, floods, hailstorms, and unseasonal rainfall can completely destroy crops. A farmer without crop insurance bears the full financial burden of such losses, which can amount to thousands of rupees per acre. Small and marginal farmers, who already operate on razor-thin margins, often lack the resources to recover from such setbacks. 

Wild Animal Attacks

In regions prone to wild animal incursions — like elephants, rabbits, wild boars, and monkeys — farmers frequently lose significant portions of their crops. Without insurance, they need to bear these losses alone. 

Increased Dependency on Loans

Farmers without crop insurance to cover damages from perils, frequently rely on loans to recover from crop failures. High-interest loans from informal sources often lead to a cycle of debt, making recovery even harder. 

Why Farmers Avoid Crop Insurance 

Despite its numerous benefits, many farmers in India fail to understand the Importance of Crop Insurance and remain uninsured. The reasons include: 

Lack of Awareness: Many farmers are unaware of crop insurance schemes or how they work. 

Perceived Cost: Farmers assume that the insurance premiums are expensive, without realising how affordable they can be. 

Complex Processes: Farmers often feel intimidated by the documentation and procedures involved in insurance enrollment. 

These misconceptions prevent farmers from taking advantage of a safety net that can save them from financial ruin. 

Read More: https://kshema.co/understanding-the-importance-of-crop-insurance/

[farmerstrend]

Dehaulming in Potato Production: Methods, Benefits, and Risks

“Learn about dehaulming in potato production, a crucial practice for hardening tuber skins and minimizing post-harvest damage, with insights into different methods and their impact on crop health.” “Discover the importance of dehaulming in potato farming, including the benefits, risks, and methods like haulms cutting, pulling, and paraquat spray to optimize your harvest.” “Explore how dehaulming…

[umangharyana]

सरसों में सिंचाई करने से पहले पढ़ ले ये जरूरी खबर, पूरे पौधे को नष्ट कर देगा ये रोग

जयपुर: राजस्थान के किसानों के लिए सरसों की फसल पर एक महत्वपूर्ण कृषि एडवाइजरी जारी की गई है। बीकानेर स्थित स्वामी केशवानंद राजस्थान कृषि विश्वविद्यालय (SKRUM) ने किसानों को सलाह दी है कि सरसों में पहली सिंचाई सावधानी से करें, वर्ना कॉलर रोट नामक खतरनाक बीमारी का खतरा बढ़ सकता है। यह बीमारी फसल को न केवल कमजोर करती है, बल्कि अगर समय रहते इसका इलाज न किया जाए, तो पूरी फसल नष्ट हो सकती है। कॉलर रोट…

[gay-caesar-truther]

Tehe drew my fucked up scientist <3

I'm also putting their whole backstory below uhh

Cw for self harm, suicide attempts, human experimentation and death

Name: Vespa Rubedo Valentine

Age: 26

Gender: Agender, they/them

Sexuality: Pansexual

Other- 

Severe phobia of the cold 

Loves bugs :3

Vespa was born in a very science focused Vault- mostly focusing on inducing mutations in various species in order to forcibly adapt them to a post-nuclear environment. 

Ves' mother, Dr. Ruby Valentina focused primarily on crop species and inducing harmful mutations in pests as a way to prevent crop loss. 

Ruby wasn't married, didn't have a partner nor did she intend to have either, but wanted a child- Both for the benefit of the vault and a means to have a tangible legacy, so agreed with a fellow vault dweller that he’d help give her a child- but would have no familial contact with Ves. 

Ves’ early childhood was mostly uneventful. Ruby gave Vespa the nickname “Cricket” due to how energetic and chatty they were. 

However, Vespa was about 4 they got infected with an experimental microbe after sneaking into the labs to visit their mother at work (it was not intended to be a pathogen but alas) and made them INCREDIBLY sick, causing permanent damage to their lungs, immune system, blood platelets. Ves was essentially bedridden for years, being constantly monitored, subjected to experimental treatments, almost dying several times. The microbe didn't affect adults severely, but given the example Ves was providing- was pretty devastating to kids. They were essentially home schooled by their mother and kept isolated from the other children until one of the experimental treatments proved toxic to the microbe and Ves was able to leave isolation.

At the age of 10 Ves was cured of their infection, and found in good enough health to go to school. However due to being the "new" kid in a Vault, and well known for being really sick/unhealthy/’diseased’ Ves struggled to make friends, or connect with the other children. 

They were subjected to significant bullying- the other children purposefully playing games that Ves couldn't join in with, being pushed and hit, having things thrown at them- etc, etc. As they aged the bullying just got more violent and aggressive. 

Ves became jaded and bitter, choosing to isolate themselves- not trying to make friends, focusing exclusively on their studies.

They would sit with their mother in the lab while she worked- learning about the various insects that would blight crops, and what insects could be used as natural pest control (start of their bug obsession), assisting with her research more and more as they aged and their own scientific knowledge improved. Their mother was the only real social contact they had.

When they were 17, around 3 months before Ves’ 18th birthday-  Ruby decided to leave the Vault and take her research to the NCR- people needed it, this could save lives by preventing food shortages but she didn't want to expose Ves to dangers of the wasteland, and as they were almost an adult make the decision to leave them behind for their own safety. She knew her child was determined and headstrong so decided not to leave any clues as to where she went, or why, in the hopes of dissuading Ves from following . 

She left instructions to the other adults in the Vault on how to help Ves cope with this change, hoping Ves would be forced to interact with others and develop a healthy social life now she wasn’t there for Ves to cling to. Ves did not give them the chance, isolating themselves in their home/ their mothers lab. Thinking that it was something THEY did that caused their mother to leave. They decided to forgo human contact entirely, it was something that had only caused them pain- As far as Ves saw it humanity was inherently cruel and inherently flawed, studying the social behavior of insects (ants and termites primarily) and comparing the “community focus” to what they’d experienced in the vault . They turned their interest towards solitary predatory insects (Tarantulas, Centipedes, parasitic wasps) as an example of how to be- fierce, independent, successful on their own and on their own merit. Any attempts to reach out by fellow vault dwellers were rejected- didn't need it, they would be okay on their own, these people were below them. 

Ves only left the lab at night to steal food from the canteen, the rest of the time they stayed locked away. Obviously the isolation and abandonment issues did some major damage to their mental health, they started self harming, and experimenting on themselves. They used the excuse of trying to make themselves tougher, conditioning themselves to have a high pain tolerance, so they can be strong, and only rely on themselves.

 In this time period they tried to take their own life by drinking random chemicals several times, fortunately their mothers work didn't involve hazardous chemicals so being unwell for a few days was the worst that happened (To this day being unwell is majorly upsetting to them- reminding them of both their childhood, and attempts on their life). Inspired by both their existing knowledge of invertebrates, and reading about the strength of ants, the toughness of carapace, etc Ves’ desire to be more like an insect branched out from just emotional resilience and solitary survival and into somehow gaining these physical characteristics. 

That in order to survive humanity had to be like insects- driven, independent, not beholden to emotional attachment, with the strength and sturdiness to allow them to thrive on their own. They began experimenting with attempting to forcibly mutate mammals via chemical exposure, genetic manipulation, on turning mammals into insects (or at least giving them all of the desirable features of them)

After a series of very successful tests on lab mice, and having no larger test subjects Ves thought they'd do the residents of the Vault a favor, granting them the gift and the mercy to be free of suffering that is being human, deciding to test their formula on them.

Maybe other people would be grateful, and Ves would get the adoration they secretly desired if they saved them from being mammals and made them stronger. 

Ves snuck out in the night, spiking the food and the air supply with their formula, and routing clean water and air to their own quarters- They were a good scientist, needed to observe the effects if they were ever going to be able to reproduce this on a larger scale (The world). They could wait- the formula had to be perfect before they’d use it on themselves. 

 To put it bluntly the test was a disaster- the changes started within hours, but the other Vault dwellers did not survive the physical stress. It took months of living with excruciating mutations, organ failures, and open wounds but eventually the whole Vault was wiped out. 

Ves decided it was their vault, they simply didn't want to be better than what they were. They hated Ves so much they'd rather die than watch them succeed. Ves took over the whole Vault, cleaned up the half mutated corpses and started again. After this failure Ves attempted to take their own life- again, but after waking up alive they went back to work- determined to not leave their great work incomplete, nor fail again.  

They Set traps for innocent wastelanders so they could serve as test subjects, and continue working to find the perfect formula to free people from the shackles of humanity. 

[cybermanoloart]

6th video in our month of plants serie!!!

And this one is of a plant we both love (those little pompoms)

We're two sisters collaborating on this video serie

@cybermanolol is in charge of the art and the editing 🎨 📽️ and @_chalulu_ is the one doing all the plant research and she's also the voice 📝🗣️

@_chalulu_ my sources are:

- Le régal végétal by François Couplan

@cybermanolol Getting the hang of gouache, don't you think? Loving these earthy, dull colours with the pops of bright yellow :)

Choose your harvesting location well:

Do not enter private property and never harvest in a protected area. Also avoid roadsides or polluted sites.

Be sure to correctly identify everything you pick so as not to damage a rare species or poison yourself.

When in doubt, abstain or call someone with the relevant competence.

Harvest plants sparingly, only where they are abundant and never collect too much.

Take only as needed and do not pull out the entire crops.

Wash before eating.

Carefully sort and wash the crop. Be careful, only cooking can prevent certain diseases or parasites such as echinococcosis or liver fluke.